New Delhi says the long-awaited US bilateral trade agreement will not be finalized until Washington offers Indian exporters a tariff rate better than their competitors get
WASHINGTON and NEW DELHI, September 6, 2026
The final act of one of the Trump administration’s most consequential trade negotiations has stalled on a single word: preferential. India will not sign off on the completed text of its bilateral trade agreement with the United States, Commerce and Industry Minister Piyush Goyal said this week, until Washington commits to a tariff rate that gives Indian goods a measurable price advantage over rival exporters such as Vietnam and Bangladesh in the American market.
“As soon as the US is able to give us the preferential rate in comparison to our competition, we will finalise the bilateral trade agreement and announce the final details,” Goyal told a national workshop on leveraging free trade agreements in New Delhi, in remarks first reported by Indian outlets on September 3 and picked up by Bloomberg on September 4. According to the Bloomberg account, Goyal said India is watching the tariff treatment available to competitors including Vietnam and Bangladesh, and wants rates that are either better than theirs or reduced to zero.
The statement is the clearest public articulation yet of why a deal that both governments celebrated as substantially complete in February remains unsigned in September, and it lays down a marker with real consequences for American importers, retailers, and manufacturers who have spent the year planning around an agreement that keeps receding just as it appears within reach.
How the Relationship Fell Apart, and Came Back
To understand why a single rate schedule can hold up a completed agreement, it helps to recall how volatile the past two years have been. The United States and India entered 2025 talking optimistically about an early trade deal, with President Trump declaring that spring that talks were “going great.” The mood curdled over the summer of 2025. Washington folded India into its reciprocal tariff system at rates that climbed steeply, and then, in August 2025, the administration doubled the burden with an additional penalty tied to India’s continued purchases of Russian crude oil, pushing effective duties on many Indian goods to 50 percent, among the highest faced by any major US trading partner at the time. Indian exporters of garments, gems, shrimp, and engineering goods reported canceled orders within weeks, and New Delhi called the measures unjustified while pointedly declining to halt Russian energy purchases.
The legal ground then shifted underneath both governments. In February 2026, the US Supreme Court ruled that the International Emergency Economic Powers Act does not authorize the President to impose tariffs, striking down the statutory basis for the reciprocal tariff system and forcing the administration to terminate those duties and rebuild its tariff architecture on other authorities. The disruption created an opening. Within days of the ruling, Washington and New Delhi announced the February framework, converting a punitive standoff into a negotiated 18 percent rate and a package of Indian purchase commitments. Officials on both sides described the deal as transformational. What they did not say, and what has become clear since, is that the hardest question, India’s relative position against its export competitors, had been deferred rather than resolved.
A Deal Announced, But Not Finished
The current impasse is best understood against the arc of the past eighteen months. Relations between the two countries deteriorated sharply in mid-2025, when President Trump announced he would be “substantially raising” tariffs on Indian goods amid disputes over market access and India’s purchases of Russian energy. The pressure campaign gave way to negotiation, and in February 2026 the two governments announced what the White House called a historic trade framework, accompanied by a joint statement and fact sheet.
Under that framework, the United States applies a reciprocal tariff rate of 18 percent on originating goods of India, covering categories including textiles and apparel, leather and footwear, plastics and rubber, organic chemicals, home decor, artisanal products, and certain machinery. The February fact sheet held out a further prize: subject to the successful conclusion of an interim agreement, the United States would remove the reciprocal tariff entirely on a wide range of goods including generic pharmaceuticals, gems and diamonds, and aircraft parts. India, for its part, committed to purchase 500 billion dollars of US energy products, aircraft and aircraft parts, precious metals, technology products, and coking coal over five years, one of the largest procurement pledges attached to any US trade arrangement.
Indian officials framed the 18 percent rate as a substantial win at the time, a steep reduction from the punitive levels threatened in 2025. Goyal himself told Indian media in February that the deal cut tariffs on Indian exports to 18 percent. What his remarks this week make clear is that New Delhi never regarded 18 percent as the finish line. The finish line, in India’s view, is a rate that beats the competition.
The Vietnam and Bangladesh Benchmark
The competitive logic behind Goyal’s position is straightforward and, trade economists note, commercially rational. India’s flagship export sectors to the United States, textiles, apparel, leather goods, footwear, and light manufacturing, compete head-to-head with Vietnam and Bangladesh, both of which secured their own tariff arrangements with Washington during the reciprocal tariff negotiations of 2025. If Indian apparel enters the United States at 18 percent while a functionally identical garment from a competitor enters at a similar or lower rate, the February deal delivers India no relative gain, however dramatic the reduction from threatened levels.
A preferential rate would change that calculus. Lower relative duties translate directly into price competitiveness at the American checkout counter, and for thin-margin categories like garments and footwear, a few percentage points of tariff differential can determine where a sourcing contract lands. Indian officials have suggested that without such an edge, Indian companies could remain at a structural disadvantage even after the agreement is signed, which would make the deal politically difficult to defend at home.
Goyal paired the demand with a display of confidence in India’s alternatives. He told the New Delhi workshop that India has now concluded nine free trade agreements spanning economies representing about 60 trillion dollars of GDP, providing preferential access to nearly two-thirds of global trade. With agreements in the pipeline, he said, India could eventually reach around 75 percent of global trade at tariff rates lower than those faced by its competitors. The India-United Kingdom agreement entered into force on July 15, agreements with Mauritius, Oman, the United Arab Emirates, and Australia are operational, and deals with the European Free Trade Association, New Zealand, and the 27-member European Union are queued to follow. The message to Washington was not subtle: India has other doors, and they are opening.
He also pointed to export momentum as evidence that India is negotiating from strength rather than desperation. India’s exports in the first four months of the current fiscal year reached about 317 billion dollars, up from 280 billion dollars in the same period a year earlier, an increase Goyal put at 36 to 37 billion dollars, with the seasonal acceleration toward Christmas and the January-to-March quarter still ahead.
The View From Washington
For the Trump administration, the Indian demand presents an awkward structural problem. The reciprocal tariff architecture built in 2025 and rebuilt after the Supreme Court’s February 2026 ruling against the emergency-powers tariffs was designed around rough parity among trading partners in similar situations, with deviations earned through concessions. Granting India a rate visibly better than Vietnam’s or Bangladesh’s would invite every other partner that signed a framework to reopen its own terms, a cascade the US Trade Representative’s office has worked to avoid all year. Washington has preferred to speak of removing tariffs on specific product lines, as contemplated in the February fact sheet, rather than committing to an across-the-board preferential rate.
At the same time, the administration has strong reasons to want the Indian agreement closed. The 500-billion-dollar purchase commitment is a centerpiece of the administration’s claim that its tariff strategy generates concrete wins for American energy, aerospace, and technology exporters. India is also central to the administration’s supply chain diversification agenda, the effort to shift electronics, pharmaceutical, and textile sourcing away from China. Boeing aircraft, US liquefied natural gas, and American coking coal all have identified Indian buyers waiting on final terms. Every month the agreement sits unsigned is a month those transactions remain contingent.
Trade lawyers following the talks note that the February framework’s own language gives India leverage: the removal of reciprocal tariffs on generic pharmaceuticals, gems, and aircraft parts was made subject to the successful conclusion of the interim agreement, meaning American importers in those sectors are also waiting on the endgame New Delhi is now conditioning.
What It Means for US Businesses
For American companies, the standoff prolongs a costly limbo. Importers of Indian goods continue to pay the 18 percent reciprocal rate on covered categories, a cost that flows through to consumer prices in apparel, home goods, and jewelry. US pharmaceutical distributors, which rely heavily on Indian generic manufacturers for a large share of American prescription volume, are watching the promised tariff removal on generics sit in escrow. Gem and jewelry importers, concentrated in New York’s diamond district and dependent on Indian cutting and polishing, face the same suspended relief.
Exporters have their own stake. American energy companies, aircraft manufacturers, and mining firms are the intended beneficiaries of the Indian purchase commitments, and industry groups have quietly pressed the administration to close the deal so contracted volumes can begin flowing. Agricultural exporters, long frustrated by Indian barriers, worry that a prolonged stalemate could see their priorities traded away in the final horse-trading over rates.
The uncertainty also complicates sourcing decisions with multi-year horizons. Retailers deciding in the fall of 2026 where to place orders for the 2027 season must guess whether Indian goods will carry an 18 percent duty, something lower, or a preferential rate that undercuts Vietnam. Sourcing consultants report that some buyers are splitting orders across countries as a hedge, sacrificing scale economies for optionality, a pattern that echoes the broader fragmentation of Asian supply chains under the reciprocal tariff system.
The Generic Drug Question
No sector illustrates the stakes of the suspended endgame better than pharmaceuticals. Indian manufacturers supply a large share of the generic medicines dispensed in the United States, a dependency that spans antibiotics, cardiac drugs, diabetes treatments, and oncology generics. The February framework promised to remove the reciprocal tariff on generic pharmaceuticals upon conclusion of the interim agreement, recognition that taxing low-margin generics functions almost entirely as a tax on American patients and insurers rather than as leverage over Indian producers.
Until the deal is signed, that removal sits in suspension. Pharmacy benefit managers and hospital purchasing organizations have warned throughout the year that sustained tariffs on generics feed through to drug shortages, because manufacturers of the cheapest products exit the market rather than absorb duties. The administration’s separate Section 232 pharmaceutical tariffs sharpened the industry’s focus: patented products from most countries face duties reaching 100 percent under the tiered structure that took effect July 31, while patented pharmaceuticals from the European Union, Japan, Korea, Switzerland, and Liechtenstein, allies that concluded deals, face only 15 percent, according to trade compliance trackers. That is precisely the kind of preferential differential India is now demanding for its own exports, and Indian negotiators cite the pharmaceutical precedent as proof that Washington can and does discriminate among partners when it wants an agreement badly enough.
The Politics of Patience
Both governments face domestic clocks. In India, Prime Minister Narendra Modi’s government has presented the trade negotiation as proof that India can engage Washington from a position of strength, and signing a deal that leaves Indian exporters level with or behind Bangladesh would hand the opposition an easy critique. Goyal’s insistence on a preferential rate is, in that sense, as much a domestic political requirement as a commercial one. His remarks emphasized that every one of India’s nine concluded agreements protected sensitive sectors, farmers, fishermen, small enterprises, pharmaceuticals, and textiles among them, and that the American deal would be held to the same standard.
In Washington, the administration is balancing its India ambitions against the credibility of its broader tariff architecture, and there is little sign of panic. Officials have pointed to the February framework as evidence the relationship is fundamentally on track, and the two sides continue technical work even as the political finish line holds. Analysts at trade-focused research groups note that the remaining gap is narrow by the standards of trade negotiations, a rate schedule rather than a structural disagreement, but that narrow gaps between confident governments can persist for a long time.
What would break the deadlock? Observers point to three possibilities. Washington could offer zero-duty treatment on a targeted basket of Indian export priorities, delivering the competitive edge Goyal demands without disturbing headline parity among partners. India could accept sequenced relief, signing now in exchange for scheduled rate reductions tied to purchase-commitment milestones. Or a leaders-level intervention, of the kind that produced the February breakthrough, could simply order the gap closed. Until one of those happens, the largest democracy and the largest economy will remain, in the words of one New Delhi analyst, ninety-five percent married and entirely unsigned.
What Economists Say About Preferential Margins
The economics literature on trade preferences suggests Goyal’s demand is more than posturing. Studies of apparel sourcing consistently find that buyers consolidate orders in whichever qualifying country offers the lowest landed cost, and that tariff differentials of even two to three percentage points shift billions of dollars in orders over a sourcing cycle. Bangladesh built its garment industry substantially on duty-free access to European markets that its competitors lacked; Vietnam’s export boom of the late 2010s tracked its accumulating web of preferential agreements. India, despite a larger workforce and deeper industrial base than either, has repeatedly lost sourcing decisions on precisely these margins.
The same logic explains Washington’s hesitation. The reciprocal system’s architects argue its credibility rests on partners believing that comparable openness earns comparable treatment. Reward one partner’s holdout with a better rate, the argument runs, and every future negotiation begins with the other side waiting for a sweetener. Administration officials have watched Japan, Korea, the European Union, and Vietnam implement their frameworks on schedule, and are reluctant to teach the lesson that patience beats compliance. The India file has therefore become a test of the entire system’s design: whether it can accommodate a partner that is too large to pressure and too important to lose.
There is also a technical middle ground that negotiators on both sides have hinted at. Rules of origin, quota structures, and product-specific staging can create effective preferences that never appear as a headline rate. India’s own agreements use such machinery extensively, and trade lawyers in both capitals suggest the eventual landing zone will look less like a single preferential number and more like a lattice of product-level outcomes that lets each government claim victory in its own vocabulary.
The Bigger Strategic Frame
Beyond the rate tables, the negotiation carries weight that both capitals understand extends well past commerce. India is the linchpin of Washington’s Indo-Pacific economic strategy, the only economy with the scale to absorb manufacturing capacity migrating out of China at the volume American planners envision. The February framework was announced amid a flurry of defense, technology, and energy cooperation agreements, and officials in both governments have described the trade deal as the economic foundation of a generational realignment. That context cuts both ways. It gives New Delhi confidence that Washington will not walk away over a rate schedule, and it gives Washington reason to believe India will not let the relationship founder over percentage points.
Geopolitics has also complicated the file in ways neither side controls. India’s continued purchases of Russian crude remain an irritant in Washington, even after the 2025 penalty tariffs were swept away with the rest of the emergency-powers regime. American lawmakers periodically press for the issue to be relitigated in the trade context, while Indian officials insist energy security is not negotiable. Meanwhile, India’s parallel negotiations with the European Union, concluded in 2026, and its deepening arrangements with the United Kingdom, Australia, and New Zealand give Goyal’s talk of alternatives genuine substance. Every agreement India signs elsewhere marginally reduces the urgency of the American deal, a dynamic New Delhi’s negotiators are content to let time amplify.
Trade economists caution against reading the standoff as failure. Measured against where the relationship stood a year ago, 50 percent duties, canceled orders, and public recrimination, an argument over the size of India’s advantage is a remarkable de-escalation. The two governments are no longer negotiating whether to have a preferential relationship, only how preferential it will be. Few of the administration’s trade files can claim as much.
For US importers and exporters alike, the practical advice from trade counsel this week was consistent: model both scenarios, maintain the hedges, and watch the competition benchmark. India has told Washington exactly what it needs to sign. The question now is whether the administration decides that closing its marquee bilateral deal is worth the precedent of putting one partner ahead of the rest of the queue.